Phase I Radiosensitization Study of GW572016 With Biologic Correlates in Locoregionally Recurrent Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Lapatinib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 14 Aug 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.